Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-01-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-022-04376-8 |
| _version_ | 1797958575200403456 |
|---|---|
| author | Robert J. Kimmerling Mark M. Stevens Selim Olcum Anthony Minnah Madeleine Vacha Rachel LaBella Matthew Ferri Steven C. Wasserman Juanita Fujii Zayna Shaheen Srividya Sundaresan Drew Ribadeneyra David S. Jayabalan Sarita Agte Adolfo Aleman Joseph A. Criscitiello Ruben Niesvizky Marlise R. Luskin Samir Parekh Cara A. Rosenbaum Anobel Tamrazi Clifford A. Reid |
| author_facet | Robert J. Kimmerling Mark M. Stevens Selim Olcum Anthony Minnah Madeleine Vacha Rachel LaBella Matthew Ferri Steven C. Wasserman Juanita Fujii Zayna Shaheen Srividya Sundaresan Drew Ribadeneyra David S. Jayabalan Sarita Agte Adolfo Aleman Joseph A. Criscitiello Ruben Niesvizky Marlise R. Luskin Samir Parekh Cara A. Rosenbaum Anobel Tamrazi Clifford A. Reid |
| author_sort | Robert J. Kimmerling |
| collection | DOAJ |
| first_indexed | 2024-04-11T00:20:53Z |
| format | Article |
| id | doaj.art-8f694796722146e58147a51a6af93ce3 |
| institution | Directory Open Access Journal |
| issn | 2399-3642 |
| language | English |
| last_indexed | 2024-04-11T00:20:53Z |
| publishDate | 2023-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Communications Biology |
| spelling | doaj.art-8f694796722146e58147a51a6af93ce32023-01-08T12:18:44ZengNature PortfolioCommunications Biology2399-36422023-01-01611210.1038/s42003-022-04376-8Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurementsRobert J. Kimmerling0Mark M. Stevens1Selim Olcum2Anthony Minnah3Madeleine Vacha4Rachel LaBella5Matthew Ferri6Steven C. Wasserman7Juanita Fujii8Zayna Shaheen9Srividya Sundaresan10Drew Ribadeneyra11David S. Jayabalan12Sarita Agte13Adolfo Aleman14Joseph A. Criscitiello15Ruben Niesvizky16Marlise R. Luskin17Samir Parekh18Cara A. Rosenbaum19Anobel Tamrazi20Clifford A. Reid21TraveraTraveraTraveraTraveraTraveraTraveraTraveraTraveraDepartment of Clinical Research, Dignity Health, Sequoia HospitalDepartment of Clinical Research, Dignity Health, Sequoia HospitalDepartment of Clinical Research, Dignity Health, Sequoia HospitalWeill Cornell MedicineWeill Cornell MedicineDepartment of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount SinaiDepartment of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount SinaiDepartment of Medical Oncology, Dana-Farber Cancer InstituteWeill Cornell MedicineDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount SinaiWeill Cornell MedicineDivision of Vascular and Interventional Radiology, Palo Alto Medical FoundationTraverahttps://doi.org/10.1038/s42003-022-04376-8 |
| spellingShingle | Robert J. Kimmerling Mark M. Stevens Selim Olcum Anthony Minnah Madeleine Vacha Rachel LaBella Matthew Ferri Steven C. Wasserman Juanita Fujii Zayna Shaheen Srividya Sundaresan Drew Ribadeneyra David S. Jayabalan Sarita Agte Adolfo Aleman Joseph A. Criscitiello Ruben Niesvizky Marlise R. Luskin Samir Parekh Cara A. Rosenbaum Anobel Tamrazi Clifford A. Reid Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements Communications Biology |
| title | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_full | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_fullStr | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_full_unstemmed | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_short | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| title_sort | publisher correction a pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements |
| url | https://doi.org/10.1038/s42003-022-04376-8 |
| work_keys_str_mv | AT robertjkimmerling publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT markmstevens publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT selimolcum publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT anthonyminnah publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT madeleinevacha publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT rachellabella publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT matthewferri publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT stevencwasserman publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT juanitafujii publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT zaynashaheen publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT srividyasundaresan publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT drewribadeneyra publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT davidsjayabalan publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT saritaagte publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT adolfoaleman publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT josephacriscitiello publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT rubenniesvizky publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT marliserluskin publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT samirparekh publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT caraarosenbaum publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT anobeltamrazi publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements AT cliffordareid publishercorrectionapipelineformalignancyandtherapyagnosticassessmentofcancerdrugresponseusingcellmassmeasurements |